Telegraph Hill Partners raises $525m fifth fund for new life science and healthcare investments

Telegraph Hill Partners raises $525m fifth fund for new life science and healthcare investments

Published: 01-07-2022 14:55:00 | By: Pie Kamau | hits: 2936 | Tags:

Telegraph Hill Partners (THP), a venture capital and growth equity firm dedicated to building life science and healthcare technology businesses, announced it has closed on THP V, a new $525 million investment fund.  

The fund will make investments in innovative companies that are commercializing advanced technologies in areas including life science tools, reagents, specialty chemistries, medical technology, medical devices, diagnostics, healthcare IT, healthcare services, agriculture and animal health.  THP V will be managed by a team close to major life science and medical innovation hubs, and includes Matt MackowskiDeval LashkariTom RaffinJeanette WelshAlex EfronKate Cilio and Linda Gregoire in San FranciscoPaul Grossman in San DiegoRob Hart in MiamiAlex Herzick and Rob Capone in Research Triangle Park; and Gary Curtis in New Haven.

Matt Mackowski, Chairman, THP: "We are grateful to our limited partners for their continued support for our team and investment philosophy of building long-term value through company development. We particularly thank the management and staff of our current and prior portfolio companies for their exceptional performance which enabled the formation of THP V, our largest fund since we formed Telegraph Hill Partners 21 years ago." 

Consistent with its previous funds, THP V will invest in innovative companies across the lifecycle from startup to fully scaled.  Investments will be structured to effectively address the capital needs of each company and its founders, and will include startup and growth capital, existing shareholder liquidity events, acquisitions/buyouts and corporate divestitures.